OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis
Xiaoxin Li, Hongzhao Qi, Weigang Cui, et al.
Molecular Therapy (2022) Vol. 30, Iss. 10, pp. 3118-3132
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

CRISPR/Cas9 therapeutics: progress and prospects
Tianxiang Li, Yanyan Yang, Hongzhao Qi, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 304

Autophagy‐associated non‐coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 18

BioDeepfuse: a hybrid deep learning approach with integrated feature extraction techniques for enhanced non-coding RNA classification
Anderson P. Avila-Santos, Breno L. S. de Almeida, Robson Parmezan Bonidia, et al.
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-12
Open Access | Times Cited: 9

Non‐coding RNAs to treat vascular smooth muscle cell dysfunction
Simon Brown, Eftychia Klimi, Wilfried A.M. Bakker, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 8

Protective effect and mechanism of ginsenoside Rg2 on atherosclerosis
Qianqian Xue, Tao Yu, Zhibin Wang, et al.
Journal of Ginseng Research (2022) Vol. 47, Iss. 2, pp. 237-245
Open Access | Times Cited: 28

piRNA-823 is a novel potential therapeutic target in aortic dissection
Min Li, Gang Li, Yanyan Yang, et al.
Pharmacological Research (2023) Vol. 196, pp. 106932-106932
Open Access | Times Cited: 19

Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression
Zhigang Chen, Dasheng Tian, Xueran Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 13

Unique regulatory roles of ncRNAs changed by PM2.5 in human diseases
Bo He, Hai-Ming Xu, Haowen Liu, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 255, pp. 114812-114812
Open Access | Times Cited: 11

Role of succinylation modification in central nervous system diseases
Chao Wang, Weigang Cui, Bing Yu, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102242-102242
Closed Access | Times Cited: 4

Innovative Approaches in Atherosclerosis Treatment: Harnessing Traditional Chinese Medicine to Target Long Non-Coding RNAs
Xiaofang Chen, Wen‐yan Ding, Yifan Liu, et al.
Phytomedicine (2025) Vol. 139, pp. 156488-156488
Closed Access

Targeting noncoding RNAs to treat atherosclerosis
Miron Sopić, Sandra Vladimirov, Jelena Munjas, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3

Role of novel protein acylation modifications in immunity and its related diseases
Xiaoqian Li, Tao Yu, Xiaolu Li, et al.
Immunology (2024) Vol. 173, Iss. 1, pp. 53-75
Open Access | Times Cited: 3

MiR-1909-5p targeting GPX4 affects the progression of aortic dissection by modulating nicotine-induced ferroptosis
Tao Yan, Gang Li, Zhibin Wang, et al.
Food and Chemical Toxicology (2024) Vol. 191, pp. 114826-114826
Closed Access | Times Cited: 3

Extracellular Vesicles-in-Hydrogel (EViH) targeting pathophysiology for tissue repair
Dachuan Liu, Wei Liu, Zeyu Han, et al.
Bioactive Materials (2024) Vol. 44, pp. 283-318
Closed Access | Times Cited: 3

Functions and mechanisms of protein lysine butyrylation (Kbu): Therapeutic implications in human diseases
Qianqian Xue, Yanyan Yang, Hong Li, et al.
Genes & Diseases (2022) Vol. 10, Iss. 6, pp. 2479-2490
Open Access | Times Cited: 15

Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications
Qiong Li, Li Zhou, Siyuan Qin, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115447-115447
Closed Access | Times Cited: 8

Roles of long non-coding RNAs in angiogenesis-related diseases: Focusing on non-neoplastic aspects
Daisong Li, Lili Liu, Xiangqin He, et al.
Life Sciences (2023) Vol. 330, pp. 122006-122006
Closed Access | Times Cited: 7

Activated neutrophil membrane-coated tRF-Gly-CCC nanoparticles for the treatment of aortic dissection/aneurysm
Tianxiang Li, Yanyan Yang, Jinbao Zong, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 334-349
Closed Access | Times Cited: 2

The Multifaceted Anti-Atherosclerotic Properties of Herbal Flavonoids: A Comprehensive Review
Mei‐Wen Huang, Xuena Xie, Rong Yuan, et al.
Pharmacological Research (2024) Vol. 211, pp. 107551-107551
Open Access | Times Cited: 2

Identification of long non-coding RNA in formaldehyde-induced cardiac dysplasia in rats
Lu Zhang, Yanyan Yang, Lin Zhang, et al.
Food and Chemical Toxicology (2023) Vol. 174, pp. 113653-113653
Closed Access | Times Cited: 4

The role and medical prospects of long non-coding RNAs in cardiovascular disease
N. Kim, Woo‐Young Chung, Je‐Yoel Cho
Heart Failure Reviews (2023) Vol. 28, Iss. 6, pp. 1437-1453
Open Access | Times Cited: 4

Circular RNAs: Regulators of endothelial cell dysfunction in atherosclerosis
Tengyu Jin, Haoyuan Wang, Yuelin Liu, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 3, pp. 313-335
Closed Access | Times Cited: 1

Non-coding RNA and Atherosclerosis
Aram Adyan, Evgeny E. Bezsonov, Eugene S. Grebenshchikov, et al.
Gene Expression (2024) Vol. 23, Iss. 1, pp. 57-68
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top